Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

118

Full text

100

Free full text

Publication Types

Journal Article

117

Research Support, Non-U.S. Gov't

Clinical Trial

Randomized Controlled Trial

Review

Research Support, N.I.H., Extramural

Comparative Study

Clinical Trial, Phase I

Multicenter Study

Observational Study

Meta-Analysis

Systematic Review

Research Support, U.S. Gov't, Non-P.H.S.

Controlled Clinical Trial

Clinical Trial, Phase III

Clinical Trial, Phase II

Letter

Validation Study

Clinical Trial, Phase IV

Pragmatic Clinical Trial

Editorial

Publication Year

From

Quick links

Individual year

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Cytochrome P-450 CYP2C19""[mesh_terms]

119 Results

Searching titles within these results

CYP2C19 polymorphism and coronary in-stent restenosis: A systematic review and meta-analysis.

Yusra Pintaningrum, Ivana Purnama Dewi, Hendy Bhaskara Perdana Putra, Idar Mappangara, Muzakkir Amir, Irawan Yusuf, Agussalim Bukhari

F1000Research 2025;11():346

Free Full Text

Abstract

The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19.

Yao Yang, Joshua P Lewis, Jean-Sébastien Hulot, Stuart A Scott

Expert opinion on drug metabolism & toxicology 2016;11(10):1599-617

Free Full Text

Abstract

Pharmacokinetic drug interaction profiles of proton pump inhibitors: an update.

Ralph-Steven Wedemeyer, Henning Blume

Drug safety 2015;37(4):201-11

Free Full Text

Abstract

Utility of the C-pantoprazole breath test as a CYP2C19 phenotyping probe for children.

Keith Feldman, Gregory L Kearns, Robin E Pearce, Susan M Abdel-Rahman, James Steven Leeder, Alec Friesen, Vincent S Staggs, Andrea Gaedigk, Jaylene Weigel, Valentina Shakhnovich

Clinical and translational science 2022;15(5):1155-1166

Free Full Text

Abstract

Comparison between clopidogrel and ticagrelor in CYP2C19 loss-of-function alleles coronary artery disease and stroke patients: a meta-analysis.

Mohamed Abouzid, Ibraheem M Alkhawaldeh, Mostafa Hossam El Din Moawad, Mahmoud Elsayed, Mohammed Elkholy, Yousr Ahmed, Younes Nabgouri, Gulnaz Bahtiyarova, Reham M Wagih

European journal of clinical pharmacology 2025;81(9):1241-1256

Free Full Text

Abstract

Physiologically-based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric population.

Laura P James, Elizabeth J Thompson, Ravinder Anand, Andrea Edginton, Daniel Gonzalez, Valentina Shakhnovich, Angela Jeong, Victória E Helfer, Stephen J Balevic, David N Collier

CPT: pharmacometrics & systems pharmacology 2024;13(8):1394-1408

Free Full Text

Abstract

Evaluation of a six-probe cocktail (caffeine, tolbutamide, omeprazole, dextromethorphan, midazolam, and digoxin) approach to estimate hepatic drug detoxification capability and dosage requirements after a single oral dosing in healthy Chinese volunteers.

Seok Hwee Koo, Gaik Hong Soon, Alain Pruvost, Henri Benech, Tiing Leong Ang, Edmund Jon Deoon Lee, Daphne Shih Wen Ang

Naunyn-Schmiedeberg's archives of pharmacology 2022;395(7):815-826

Full Text

Abstract

CYP2C19 metabolizer status and clopidogrel efficacy in the Secondary Prevention of Small Subcortical Strokes (SPS3) study.

Caitrin W McDonough, Leslie A McClure, Braxton D Mitchell, Yan Gong, Richard B Horenstein, Joshua P Lewis, Thalia S Field, Robert L Talbert, Oscar R Benavente, Julie A Johnson, Alan R Shuldiner

Journal of the American Heart Association 2016;4(6):e001652

Free Full Text

Abstract

Comparison of Tegoprazan and Lansoprazole in Patients With Erosive Esophagitis up to 4 Weeks: A Multi-Center, Randomized, Double-Blind, Active-Comparator Phase 4 Trial.

Seong Woo Jeon, Sang Jin Lee, Do Hoon Kim, Seon-Young Park, Jeong Eun Shin, Yu Kyung Cho, Sang Kil Lee, Hye-Kyung Jung, In Kyung Sung, Ju Yup Lee, Su Jin Hong, Oh Young Lee, Suck Chei Choi, Gwang Ha Kim, Moo In Park, Cheol Min Shin, Young Hoon Youn, Jin Woong Cho, Seung Young Kim, Ok Jae Lee

Neurogastroenterology and motility 2024;37(1):e14969

Free Full Text

Abstract

Genetic polymorphisms and drug interactions leading to clopidogrel resistance: why the Asian population requires special attention.

Md Shariful Hasan, Hamidon Bin Basri, Lim Poh Hin, Johnson Stanslas

The International journal of neuroscience 2013;123(3):143-54

Full Text

Abstract

Night-time gastric acid suppression by tegoprazan compared to vonoprazan or esomeprazole.

In-Jin Jang, Kyung-Sang Yu, SeungHwan Lee, Eunsol Yang, Seokuee Kim, Bongtae Kim, Boram Kim, Yechan Kim, Sung Sup Park, Geun Seog Song

British journal of clinical pharmacology 2022;88(7):3288-3296

Free Full Text

Abstract

Short- and long-term effects of body weight, calorie restriction and gastric bypass on CYP1A2, CYP2C19 and CYP2C9 activity.

Kine Eide Kvitne, Veronica Krogstad, Christine Wegler, Line Kristin Johnson, Marianne K Kringen, Markus Herberg Hovd, Jens K Hertel, Maria Heijer, Rune Sandbu, Eva Skovlund, Per Artursson, Cecilia Karlsson, Shalini Andersson, Tommy B Andersson, Jøran Hjelmesaeth, Anders Åsberg, Rasmus Jansson-Löfmark, Hege Christensen, Ida Robertsen

British journal of clinical pharmacology 2022;88(9):4121-4133

Free Full Text

Abstract

Association of genetic polymorphisms with warfarin dose requirements in Chinese patients.

Yundan Liang, Zhiyu Chen, Gang Guo, Xuemei Dong, Chunting Wu, He Li, Tong Wang, Bingying Xu

Genetic testing and molecular biomarkers 2014;17(12):932-6

Free Full Text

Abstract

Interpretation of Pharmacometabolomics Results: Fingerprint of Drug Exposure or Confounder Effects? Insights from a Urinary Metabolomics Study with Voriconazole in Healthy Participants.

Kristine Chobanyan-Jürgens, Amin Muhareb, Moritz Niesert, Camilo Scherkl, Andreas D Meid, Claire Cannet, Dora Pituk, Georg F Hoffmann, Julia C Stingl, Andreas Ziegler, Antje Blank

International journal of molecular sciences 2026;27(10):

Full Text

Abstract

The Effect of CYP2C19 and Nongenetic Factors on Clopidogrel Responsiveness in the MENA Region: A Systematic Review.

Hazem Elewa, Zainab Ali

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2020;25():1076029619875520

Free Full Text

Abstract

Results: 1 – 15 / 119

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Cytochrome P-450 CYP2C19""[mesh_terms]

CYP2C19 polymorphism and coronary in-stent restenosis: A systematic review and meta-analysis.

The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19.

Pharmacokinetic drug interaction profiles of proton pump inhibitors: an update.

Utility of the C-pantoprazole breath test as a CYP2C19 phenotyping probe for children.

Comparison between clopidogrel and ticagrelor in CYP2C19 loss-of-function alleles coronary artery disease and stroke patients: a meta-analysis.

Physiologically-based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric population.

Evaluation of a six-probe cocktail (caffeine, tolbutamide, omeprazole, dextromethorphan, midazolam, and digoxin) approach to estimate hepatic drug detoxification capability and dosage requirements after a single oral dosing in healthy Chinese volunteers.

CYP2C19 metabolizer status and clopidogrel efficacy in the Secondary Prevention of Small Subcortical Strokes (SPS3) study.

Comparison of Tegoprazan and Lansoprazole in Patients With Erosive Esophagitis up to 4 Weeks: A Multi-Center, Randomized, Double-Blind, Active-Comparator Phase 4 Trial.

Genetic polymorphisms and drug interactions leading to clopidogrel resistance: why the Asian population requires special attention.

Night-time gastric acid suppression by tegoprazan compared to vonoprazan or esomeprazole.

Short- and long-term effects of body weight, calorie restriction and gastric bypass on CYP1A2, CYP2C19 and CYP2C9 activity.

Association of genetic polymorphisms with warfarin dose requirements in Chinese patients.

Interpretation of Pharmacometabolomics Results: Fingerprint of Drug Exposure or Confounder Effects? Insights from a Urinary Metabolomics Study with Voriconazole in Healthy Participants.

The Effect of CYP2C19 and Nongenetic Factors on Clopidogrel Responsiveness in the MENA Region: A Systematic Review.

Results for
""Cytochrome P-450 CYP2C19""[mesh_terms]